111970-13-9 Usage
Chemical structure
The compound has a complex structure with an oxazepine ring fused to a quinazoline ring, a phenyl group, and an acetyloxy group attached to different positions of the molecule.
Pharmacological properties
The compound has potential pharmacological properties and may exhibit biological activity, making it of interest for medicinal chemistry and drug development.
Acetyloxy group
The presence of the acetyloxy group suggests potential metabolic or synthetic pathways, which could be relevant for the compound's activity and potential applications.
Unique structure
The compound's unique structure makes it an interesting target for further study and potential applications in the pharmaceutical industry.
Potential applications
Due to its pharmacological properties and unique structure, the compound may have potential applications in the development of new drugs or therapies.
Further study
Further research and study of the compound's properties, activity, and potential applications are needed to fully understand its potential and limitations in the field of medicinal chemistry and drug development.
Synthesis
The synthesis of the compound may involve complex chemical reactions and techniques, which could be of interest to researchers in the field of organic chemistry.
Structural analysis
Detailed structural analysis of the compound, including its molecular geometry, bonding, and electronic properties, may provide further insights into its potential applications and properties.
Biological activity
The compound's biological activity, including its interactions with biological targets and potential effects on cellular processes, is an important area of study for understanding its potential applications in drug development.
Metabolism
The metabolism of the compound, including its metabolic pathways and potential metabolites, may be relevant for understanding its pharmacological properties and potential applications.
Safety and toxicity
The safety and toxicity of the compound, including its potential side effects and risks, should be carefully evaluated as part of its development and application in the pharmaceutical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 111970-13-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,1,9,7 and 0 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 111970-13:
(8*1)+(7*1)+(6*1)+(5*9)+(4*7)+(3*0)+(2*1)+(1*3)=99
99 % 10 = 9
So 111970-13-9 is a valid CAS Registry Number.
111970-13-9Relevant articles and documents
New Reaction of Deoxyvasicinone. Part 6
Dunn, A. D.,Kinnear, K. I.,Norrie, R.,Ringan, N.,Martin, D.
, p. 175 - 180 (2007/10/02)
Several acylated derivatives of deoxyvasicinone 1 and its analogues were shown to exist as enols.The 3-hydroxymethyl derivative of 1 was shown to undergo rapid dehydration and products derived from an intermediate 3-methylene compound were obtained.Novel oxazepino analogues of 1 are reported.
